Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Jul 1;42(4):497-499.
doi: 10.3343/alm.2022.42.4.497.

Three Cases of False-positive Multiplex Ligation-dependent Probe Amplification of BRCA1

Affiliations
Case Reports

Three Cases of False-positive Multiplex Ligation-dependent Probe Amplification of BRCA1

Kyoung Bo Kim et al. Ann Lab Med. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST

The authors have no conflicts of interest to declare.

Figures

Fig. 1
Fig. 1
Results of initial MLPA and confirmative tests of the three cases. (A) In the first case, an initial MLPA test with the P002 kit showed abnormal signals, suggesting partial duplication of exon 11 of BRCA1. (B) However, a subsequent confirmative MLPA test using P087 showed no abnormal results. An additional P002 MLPA test using a new venous blood sample showed all signals within normal limits. (C) In the second case, an initial P002 MLPA test revealed a decreased DQ 0.57 for the probe set for exon 1a, suggesting heterozygous deletion of this exon. (D) Direct sequencing of BRCA1 exon 1a revealed a single nucleotide substitution c.-40C>T (indicated by the black arrowhead) in the two-nucleotide region flanking the probe hybridization site. (E) In the third case, an initial P002 MLPA test revealed a decreased DQ 0.69 for the probe set for exon 23. (F) Direct sequencing of exon 23 revealed c.5419A>G (indicated by the black arrowhead) in the four-nucleotide region flanking the probe hybridization site. Probe hybridization sites are indicated in black rectangles. Abbreviations: DQ, dosage quotient; MLPA, multiplex ligation-dependent probe amplification.

Similar articles

Cited by

References

    1. King MC, Marks JH, Mandell JB New York Breast Cancer Study Group, author. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science. 2003;302:643–6. doi: 10.1126/science.1088759. - DOI - PubMed
    1. Ewald IP, Ribeiro PL, Palmero EI, Cossio SL, Giugliani R, Ashton-Prolla P. Genomic rearrangements in BRCA1 and BRCA2: a literature review. Genet Mol Biol. 2009;32:437–46. doi: 10.1590/S1415-47572009005000049. - DOI - PMC - PubMed
    1. Hansen Tv, Jønson L, Albrechtsen A, Andersen MK, Ejlertsen B, Nielsen FC. Large BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer families. Breast Cancer Res Treat. 2009;115:315–23. doi: 10.1007/s10549-008-0088-0. - DOI - PubMed
    1. Oscorbin I, Kechin A, Boyarskikh U, Filipenko M. Multiplex ddPCR assay for screening copy number variations in BRCA1 gene. Breast Cancer Res Treat. 2019;178:545–55. doi: 10.1007/s10549-019-05425-3. - DOI - PubMed
    1. Han E, Yoo J, Chae H, Lee S, Kim DH, Kim KJ, et al. Detection of BRCA1/2 large genomic rearrangement including BRCA1 promoter-region deletions using next-generation sequencing. Clin Chim Acta. 2020;505:49–54. doi: 10.1016/j.cca.2020.02.023. - DOI - PubMed